Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).

Boni, C; Tiseo, M; Boni, L; Baldini, E; Recchia, F; Barone, C; Grossi, F; Germano, D; Matano, E; Marini, G; Labianca, R; Di Costanzo, F; Bagnulo, A; Pennucci, C; Caroti, C; Mencoboni, M; Zanelli, F; Prochilo, T; Cafferata, M A; Ardizzoni, A

Boni, C; Tiseo, M; Boni, L; Baldini, E; Recchia, F; Barone, C; Grossi, F; Germano, D; Matano, E; Marini, G; Labianca, R; Di Costanzo, F; Bagnulo, A; Pennucci, C; Caroti, C; Mencoboni, M; Zanelli, F; Prochilo, T; Cafferata, M A; Ardizzoni, A.

Affiliation

Boni C; Oncology Unit, S Maria Nuova Hospital, Viale Risorgimento 80, Reggio Emilia 42123, Italy.

Br J Cancer ; 106(4): 658-65, 2012 Feb 14.

Article in En | MEDLINE | ID: mdl-22240782

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2012 Document type: Article Affiliation country: Italia Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google